课题基金 / 基金详情

A DNA-Based Universal Seasonal Influenza Vaccine Phase I Safety and Immunogenicity Study

A DNA-Based Universal Seasonal Influenza Vaccine Phase I Safety and Immunogenicity Study
基于 DNA 的通用季节性流感疫苗 I 期安全性和免疫原性研究
批准号:
226228
负责人:
Kobinger Gary P
金额:
$23.24万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-03-01 至 2013-03-01

项目摘要

项目成果

Kobinger Gary P的其他基金

相似基金

相关文献

中文摘要
翻译
季节性流感感染是一个重要的医学问题。每年都有许多加拿大人患上“流感”,造成经济损失和大量的住院和死亡。目前的流感疫苗是在鸡蛋和r
英文摘要
Seasonal Influenza infection is an important medical problem. Each year many Canadians become ill with the "flu", resulting in economic loss and a substantial number of hospitalizations and deaths. The current flu vaccine is produced in chicken eggs and r
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.
  • 批准号:
    443201
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.24万
  • 财政年份:
    2021
  • 负责人:
    Kobinger Gary P
  • 依托单位:
Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.
  • 批准号:
    422757
  • 项目类别:
    Operating Grants
  • 资助金额:
    $72.8万
  • 财政年份:
    2020
  • 负责人:
    Kobinger Gary P
  • 依托单位:
Development of a safe, effective and clinically acceptable VSV-based HIV vaccine
  • 批准号:
    365026
  • 项目类别:
    Operating Grants
  • 资助金额:
    $291.22万
  • 财政年份:
    2017
  • 负责人:
    Kobinger Gary P
  • 依托单位:
Development of an animal model, a protective vaccine and monoclonal antibodies against Crimean-Congo Hemorrhagic Fever Virus
  • 批准号:
    345294
  • 项目类别:
    Operating Grants
  • 资助金额:
    $102.2万
  • 财政年份:
    2016
  • 负责人:
    Kobinger Gary P
  • 依托单位:
海外基金